Search
forResearch 10 of 1000+
- Pharmacogenetic analysis of human steroid 5α reductase type II: comparison of finasteride and dutasteride
- Pharmacogenetics of the Androgen Metabolic Pathway
- The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy
- The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches
- Pharmacogenetic Determinants of Valproic Acid Efficacy, Toxicity, and Serum Levels in Genetic Generalized Epilepsy
- Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
- ORIGINAL RESEARCH—ENDOCRINOLOGY: Comparison of the Steady‐State Pharmacokinetics, Metabolism, and Variability of a Transdermal Testosterone Patch Versus a Transdermal Testosterone Gel in Hypogonadal Men
- The effect of St. John’s wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men
- Pharmacokinetics of a new testosterone transdermal delivery system, TDS<sup>®</sup>‐testosterone in healthy males
- The Pharmacokinetics of 2.5- to 10-mg Oral Doses of Minoxidil in Healthy Volunteers
Community 7
- Pelage have presented only phase 2a. The rest of phase 2 for PP405 will be presented at a later medical meeting
- Are we underestimating systemic absorption with homemade/generic Topical Fin? (HPCH vs. PG/Ethanol formulations)
- Fin/Dut and Metabolism Speeds…
- The story of RU58841/ PSK3841
- Topical Dutasteride - Non-Hormonal, Side Effect Free 5ARI?
- 📈 Solving for very low dose topical finasteride titration intervals
- Dutasteride half life - conflicting information
Learn
— no results
Try a deeper search in learn →